Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial
Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status was updated to 'No longer looking for participants,' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The label 'Intervention / Treatment' was changed to 'Intervention/Treatment,' and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check19 days agoChange DetectedFooter revision updated from v3.5.4 to v3.5.5, indicating a newer build of the page. This change does not modify the displayed study content or user-facing functionality.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page shows a new revision label: v3.5.4 replaces v3.5.3, representing a minor update to the record. This update appears to be administrative and does not alter study details or outcomes.SummaryDifference0.0%

- Check49 days agoChange DetectedNo additions or deletions were provided in the website_changes data. This indicates that the page content underwent no recorded textual changes based on the supplied input.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision label on the page updated from v3.5.2 to v3.5.3. This is a small version update and does not alter the study information or user-facing content.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.